The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00226265

Enrollment

Registered

2005-09-26

Start date

1999-01-31

Completion date

2007-09-30

Last updated

2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Grafting, Heart Diseases, Heart Valve Diseases

Keywords

Cardiac surgery patients, Quality of Life, Recall bias, Aortic valve replacement, Mitral valve replacement, Tricuspid valve replacement, Coronary artery bypass graft surgery

Brief summary

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Detailed description

The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Cardiac surgery patients who are between the ages of 18 and 100 * Are English speaking * Able to give consent * Undergoing cardiac surgery including (but not limited to): * Aortic valve replacement (AVR) * Mitral valve replacement (MVR) * Tricuspid valve replacement (TVR) * Coronary artery bypass graft (CABG).

Exclusion criteria

* Non-cardiac surgery patients

Countries

United States

Outcome results